Availability: In Stock

ENZYME INHIBITION IN DRUG DISCOVERY AND DEVELOPMENT: THE GOOD AND THE BAD

SKU: 9780470281741

Original price was: ₹22,322.77.Current price is: ₹17,858.22.

Explore the critical role of enzyme inhibition in modern drug discovery and development with “Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad” from The Bookish Owl. This comprehensive guide offers a unique perspective, delving into both the desirable pharmacological effects and the adverse consequences of enzyme inhibition, including drug-drug interactions and toxicity. Featuring insights from over fifty leading experts, the book covers essential topics such as drug discovery strategies, medicinal chemistry, pharmacokinetics, and the manipulation of drug metabolizing enzymes. Essential for researchers in drug metabolism and pharmacokinetics (DMPK), discovery biologists, and medicinal chemists, this definitive resource bridges the gap between target biology and DMPK, fostering a deeper understanding for effective drug development.

5 in stock

Description

  • ISBN-10: 047028174X
  • ISBN-13: 978-0470281741
  • Edition: 1st
  • Publisher: John Wiley & Sons Inc
  • Publication date: 26 January 2010
  • Language: English
  • Dimensions: 16.26 x 4.45 x 24.26 cm
  • Print length: 868 pages